Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
